Staff Reporter :
The Directorate General of Drug Administration (DGDA) has formulated a guideline on the adverse side effects to Covid-19 vaccine.
DGDA Director General (DG) Big Gen Mahbubur Rahman confirmed it to media following a meeting with the experts at DGDA headquarters in the city on Tuesday afternoon.
The guideline will be sent to the Health Ministry for approval on Sunday, the DG said to the media.
Earlier on Sunday, the ministry approved the National Vaccine Deployment Plan for Covid-19.
On Monday, Directorate General of Health Services (DGHS) DG Prof ABM Khurshid Alam said according to Beximco Pharmaceuticals Ltd the vaccine would arrive by January 25.
The vaccine would be stored in Beximco’s warehouse and the first instalment of the vaccine distributed to the health authorities at the district-level within January 27.
The health authorities said nationwide vaccination would start from the first week of February.
On Monday, DGHS Additional DG Prof Meerjady Sabrina Flora said mobile medical teams would be deployed near vaccination centres to tackle any situation that emerges following an adverse impact on any vaccine recipient.
IEDCR advisor Mushtaq Hussain said vaccine recipients would have to stay 30 minutes at the vaccination centre under observation to ensure they do not have any side effects.
